Literature DB >> 237095

Drug-induced changes of dopamine turnover in striatum and limbic system of the rat.

G Bartholini, H H Keller, A Pletscher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237095     DOI: 10.1111/j.2042-7158.1975.tb09476.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

1.  Tolerability of long term clozapine treatment.

Authors:  M Schmauss; R Wolff; A Erfurth; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

3.  Interaction of benzodiazepines with neuroleptics at central dopamine neurons.

Authors:  H H Keller; R Schaffner; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-07       Impact factor: 3.000

Review 4.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.

Authors:  K L Davis; K F Faull; L E Hollister; J D Barchas; P A Berger
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release.

Authors:  J S de Belleroche; I M Gardiner
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.